Intrinsic Value of S&P & Nasdaq Contact Us

Cannonau Corp. CNNC OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score
70/100
2/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Cannonau Corp. (CNNC) generated $0.00 in operating cash flow for quarter ending 2024-03-31. After capital expenditures of $0.00, free cash flow was $0.00.

Criteria supported by this page:

  • HEALTH (83/100, Fail) — weak cash flow raises concerns about debt servicing
  • MOAT (50/100, Partial) — cash flow generation is present but not at levels indicating a wide moat

Overall SharesGrow Score: 66/100 with 2/7 criteria passed.

SharesGrow 7-Criteria Score
70/100
SG Score
View full scorecard →
VALUE
100/100
Price-to-Earnings & upside
→ Valuation
FUTURE
N/A
No coverage
PAST
25/100
→ Income
HEALTH
83/100
Debt-to-Equity & liquidity
Proven by this page
~
MOAT
50/100
Proven by this page
GROWTH
90/100
→ Income
INCOME
N/A
No coverage
Cannonau Corp. Cash Flow History
Metric TTM Q1 FY2024 Q4 FY2023 Q3 FY2023 Q2 FY2023
Operating Cash Flow $1.04K$0.00$-61.00$-56.00$1.16K
Capital Expenditure $0.00$0.00$0.00$0.00$0.00
Free Cash Flow $1.04K$0.00$-61.00$-56.00$1.16K
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message